Vol. 5 (11) pp. 1458-1464 DOI: 10.21474/IJAR01/5921

CORRELATION OF LIPID PROFILE WITH CAROTID INTIMA MEDIA THICKNESS IN NEWLY DIAGNOSED CORONARY ARTERY DISEASE PATIENTS.

and
  • Department of Medicine, Yenepoya Medical College Hospital.
  • Asst. Professor, Department of Medicine, Yenepoya Medical College Hospital.
12 Downloads 135 Views
Crossref

Download Full Paper (PDF)

How to Cite This Article

Javeed Ashfaque and Prakrithi M. D. (2017); CORRELATION OF LIPID PROFILE WITH CAROTID INTIMA MEDIA THICKNESS IN NEWLY DIAGNOSED CORONARY ARTERY DISEASE PATIENTS., International Journal of Advanced Research (IJAR), 5 (11), 1458-1464, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/5921

Corresponding Author

DR JAVEED ASHFAQUE
YENEPOYA MEDICAL COLLEGE, DERALAKATTE, MANGALORE

Article Analytics

References

  1. Silesen H, Falk E: Why not screen for subclinical atherosclerosis? Lancet 2011, 378(9792):645-646.
  2. Sengupta D, Bardhan J & Mahapatra AB?Correlation between Lipid Profile and carotid intima media thickness in cerebral ischaemia.Indian J Physiol Pharmacol 2014;58(4):354-364: ; 2013.
  3. Khan SP, Ahmed KZ & Yaqub Z?Carotid Intima -Media Thickness Correlation with Lipid Profile in Patients With Familial Hypercholesterolemia Versus Controls,Journal of the College of Physicians and Surgeon Pakistan ,Vol 21(1):30-33 2011
  4. Espeland MA ,O ?Leary DH,Terry JG ,Morgan T et al Carotid Intima ?media thickness as a surrogate for cardiovascular events in trials of HMG-CoA reductase inhibitor. Curr Control Trials,Cardiovasc Med 2005;6:3
  5. Yang C, Sun Z & Li Y?The correlation between serum lipid profile with carotid intima- media thickness and plaque,China : BMC Cardiovascular disorders ; 2014.
  6. Pillai R, Tiwari D & Jatav OP?Lipid Profile and carotid artery Intima -Media thickness in diabetic and non diabetic ischaemic stroke,International Journal of Advances in Medicine 2017 April;4(2):471-475: ; 2017.
  7. Lim S, Despres JP, Koh KK: Prevention of atherosclerosis in overweight/obese patients. - In need of novel multi-targeted approaches. Circ J. 2011, 75 (5): 1019-1027. 10.1253/circj.CJ-10-1240.
  8. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y, MEGA Study Group: Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet. 2006, 368 (9542): 1155-1163. 10.1016/S0140-6736(06)69472-5.
  9. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM, Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004, 350 (15): 1495-1504. 10.1056/NEJMoa040583.
  10. Miller NE, Thelle DS, Forde OH, Mjos OD: The Tromso heart-study. High-density lipoprotein and coronary heart-disease: a prospective case?control study. Lancet. 1977, 1 (8019): 965-968.
  11. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A: Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001, 285 (19): 2486-2497. 10.1001/jama.285.19.2486.
  12. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL: Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001, 161 (11): 1413-1419. 10.1001/archinte.161.11.1413.
  13. Bittner V, Hardison R, Kelsey SF, Weiner BH, Jacobs AK, Sopko G, Bypass Angioplasty Revascularization I: Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 2002, 106 (20): 2537-2542. 10.1161/01.CIR.0000038496.57570.06.
  14. Xydakis AM, Ballantyne CM: Role of non-high-density lipoprotein cholesterol in prevention of cardiovascular disease: updated evidence from clinical trials. Curr Opin Cardiol. 2003, 18 (6): 503-509. 10.1097/00001573-200311000-00012.
  15. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE: Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA. 2005, 294 (3): 326-333. 10.1001/jama.294.3.326.
  16. Kinosian B, Glick H, Garland G: Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med. 1994, 121 (9): 641-647. 10.7326/0003-4819-121-9-199411010-00002.
  17. Hsia SH, Pan D, Berookim P, Lee ML: A population-based, cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic disease. Am J Cardiol. 2006, 98 (8): 1047-1052. 10.1016/j.amjcard.2006.05.024.
  18. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC, Treating to New Targets I: HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007, 357 (13): 1301-1310. 10.1056/NEJMoa064278.
  19. Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS: Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 2007, 298 (7): 776-785. 10.1001/jama.298.7.776.
  20. Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM, TNT Study Group, Ideal Study Group: Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation. 2008, 117 (23): 3002-3009. 10.1161/CIRCULATIONAHA.107.713438.
  21. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999, 340 (1): 14-22. 10.1056/NEJM199901073400103.
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.